Melanocortins defend their territory: multifaceted neuroprotection in cerebral ischemia.
Tatro
Jeffrey B
JB
Division of Endocrinology, Diabetes, Metabolism and Molecular Medicine, Box 268, Tufts-New England Medical Center, and Tufts University School of Medicine, Boston, Massachusetts 02111, USA. jtatro@tufts-nemc.org
D000818:Animals; D001921:Brain / Q000378:metabolism; D002545:Brain Ischemia / Q000473:pathology* / Q000628:therapy; D006801:Humans; D008954:Models, Biological; D018696:Neuroprotective Agents / Q000494:pharmacology; D010477:Perfusion; D044104:Receptor, Melanocortin, Type 3 / Q000378:metabolism; D044105:Receptor, Melanocortin, Type 4 / Q000378:metabolism; D013997:Time Factors; D016896:Treatment Outcome; D000521:alpha-MSH / Q000378:metabolism / Q000502:physiology*
C505392:MC3R protein, human; C470072:MC4R protein, human; D018696:Neuroprotective Agents; D044104:Receptor, Melanocortin, Type 3; D044105:Receptor, Melanocortin, Type 4; D000521:alpha-MSH